Jan Kuhlmann Andersen

Jan Kuhlmann Andersen has 20 years of experience from the pharmaceutical and biotechnological industry. He is currently the COO of BioPorto Diagnostics A/S, which is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies.He has had several senior managements and key leadership positions in the Nunc Group, Fischer Scientific Products, FMC and Dako within sales, production and life science product development. Jan Kuhlman also held the Managing Director position at Cambrex Bioresearch Europe 2000-2003. Since 2007 Jan Kuhlmann was the Vice President, Sales & Marketing, Animal Health & Nutrition at Christian Hansen A/S, Denmark. Until January 1, 2015, Jan Kuhlmann Andersen was also a board member in Noscomed Medical Supply A/S and in the French Life Science company Cell Made. Jan Kuhlmann holds both a M.Sc. and Ph.D. in cell biology and immunology from the University of Copenhagen.

Position	Chairman of the Board since 2015
Year of Birth	1961
Holding of shares in Cytovac AB (as of Dec 31, 2020)	33,664
Other ongoing assignments	COO of Bioporto Diagnostics A/S
Previous Assignments (within the last 5 years)	VP at Chr. Hansen A/S and board member at Noscomed Medical Supply A/S and Cell Made.
Independent in relation to the company and its management	Yes
Independent in relation to larger shareholders	Yes